In gliomas, the expression of E-cadherin is most commonly absent or scant [87,88], and if it is present (GBM subtypes with epithelial and pseudo-epithelial differentiation), it is usually correlated with a worse prognosis [37,89]. This evidence concerns the gene CDH1 and glioblastoma.